| 产品详情 |
| Edit |   |
|---|
| Product Name | GM-CSF, Recombinant, Human, aa18-144 (CHO-expressed, CSF2) |
|---|
| Description | Purity ~95% (SDS-PAGE). GM-CSF was initially characterized as a factor that can support the in vitro colony formation of granulocyte-macrophage progenitors. It is also a growth factor for erythroid, megakaryocyte, and eosinophil progenitors. GM-CSF is produced by a number of different cell types (including T cells, B cells, macrophages, mast cells, endothelial cells, fibroblasts, and adipocytes) in response to cytokine or inflammatory stimuli. On mature hematopoietic cells, GM-CSF is a survival factor for and activates the effector functions of granulocytes, monocytes/macrophages, and eosinophils (1, 2). GM-CSF promotes a Th1 biased immune response, angiogenesis, allergic inflammation, and the development of autoimmunity (3-5). It shows clinical effectiveness in ameliorating chemotherapy-induced neutropenia, and GM-CSF transfected tumor cells are utilized as cancer vaccines (6, 7). The 22kD glycosylated GM-CSF, similar to IL-3 and IL5, is a cytokine with a core of four bundled alpha-h |
|---|
| Size | 10ug |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | SwissProt: P04141 |
|---|
| Catalog # | 145701 |
|---|
| Price | |
|---|
| Order / More Info | GM-CSF, Recombinant, Human, aa18-144 (CHO-expressed, CSF2) from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|